TipRanks
Advertisement
Advertisement

ABOS Stock Latest News

Acumen Highlights Anti-AβO Pipeline at Investor Day
Company AnnouncementsAcumen Highlights Anti-AβO Pipeline at Investor Day
2m ago
8K
ABOS
Citi ups Acumen target, opens ‘upside 90-day catalyst watch’
PremiumThe Fly
Citi ups Acumen target, opens ‘upside 90-day catalyst watch’
1d ago
ABOS
Acumen Pharmaceuticals Earnings Call: Science vs. Runway
PremiumCompany Announcements
Acumen Pharmaceuticals Earnings Call: Science vs. Runway
24d ago
ABOS
Acumen reports Q2 EPS (45c), consensus (41c)
PremiumThe Fly
Acumen reports Q2 EPS (45c), consensus (41c)
1M ago
ABOS
Acumen Pharmaceuticals Reports Q2 Results, Advances Alzheimer’s Programs
PremiumCompany Announcements
Acumen Pharmaceuticals Reports Q2 Results, Advances Alzheimer’s Programs
1M ago
8K
ABOS
ABOS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsABOS Upcoming Earnings Report: What to Expect?
1M ago
ABOS
Acumen presents new findings at AAIC conference
Premium
The Fly
Acumen presents new findings at AAIC conference
2M ago
ABOS
JCR announces Acumen exercises exclusive option for Alzheimer’s candidates
Premium
The Fly
JCR announces Acumen exercises exclusive option for Alzheimer’s candidates
3M ago
ABOS
Acumen Advances Enhanced Brain Delivery Alzheimer’s Drug Candidates
PremiumCompany Announcements
Acumen Advances Enhanced Brain Delivery Alzheimer’s Drug Candidates
3M ago
8K
ABOS
Acumen nominates two development candidates in EBD program
PremiumThe Fly
Acumen nominates two development candidates in EBD program
3M ago
ABOS
Acumen Stockholders Approve Directors and Equity Incentive Plan
PremiumCompany Announcements
Acumen Stockholders Approve Directors and Equity Incentive Plan
3M ago
8K
ABOS
Acumen Pharmaceuticals Warns Investors: Unchanged 10-K Risk Factors Still Weigh on Valuation and Share Price
PremiumCompany Announcements
Acumen Pharmaceuticals Warns Investors: Unchanged 10-K Risk Factors Still Weigh on Valuation and Share Price
4M ago
ABOS
Acumen Pharmaceuticals Bets Big on Alzheimer’s Trials
PremiumCompany AnnouncementsAcumen Pharmaceuticals Bets Big on Alzheimer’s Trials
4M ago
ABOS
Acumen Updates Q1 Results and Alzheimer’s Pipeline Progress
Premium
Company Announcements
Acumen Updates Q1 Results and Alzheimer’s Pipeline Progress
4M ago
8K
ABOS
Acumen Pharmaceuticals’ Earnings Call: Promise Amid Pressure
Premium
Company Announcements
Acumen Pharmaceuticals’ Earnings Call: Promise Amid Pressure
5M ago
ABOS
Acumen files to sell 10.83M shares of common stock for holders
PremiumThe Fly
Acumen files to sell 10.83M shares of common stock for holders
6M ago
ABOS
Options Volatility and Implied Earnings Moves Today, March 26, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 26, 2026
6M ago
CMC
ABOS
Acumen Updates Alzheimer’s Pipeline, Extends Cash Runway Into 2027
PremiumCompany Announcements
Acumen Updates Alzheimer’s Pipeline, Extends Cash Runway Into 2027
6M ago
8K
ABOS
Is ABOS a Buy, Before Earnings?
PremiumPre-Earnings
Is ABOS a Buy, Before Earnings?
6M ago
ABOS
Acumen participates in a conference call with Cantor
PremiumThe FlyAcumen participates in a conference call with Cantor
6M ago
ABOS
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
Premium
The Fly
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
6M ago
ABOS
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
Premium
Ratings
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
6M ago
ABOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >